2024

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
Becher N, Toennis T, Bertaglia E, Blomstrom Lundqvist C, Brandes A, Cabanelas N, Calvert M, Camm A, Chlouverakis G, Dan G, Dichtl W, Diener H, Fierenz A, Goette A, de Groot J, N L Hermans A, Lip G, Lubiński A, Marijon E, Merkely B, Mont L, Ozga A, Rajappan K, Sarkozy A, Scherr D, Schnabel R, Schotten U, Sehner S, Simantirakis E, Vardas P, Velchev V, Wichterle D, Zapf A, Kirchhof P
EUR HEART J. 2024;45(10):837-849.

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
Lip G, Nikorowitsch J, Sehner S, Becher N, Bertaglia E, Blomstrom-Lundqvist C, Brandes A, Beuger V, Calvert M, Camm A, Chlouverakis G, Dan G, Dichtl W, Diener H, Fierenz A, Goette A, de Groot J, Hermans A, Lubinski A, Marijon E, Merkely B, Mont L, Ozga A, Rajappan K, Sarkozy A, Scherr D, Schnabel R, Schotten U, Simantirakis E, Toennis T, Vardas P, Wichterle D, Zapf A, Kirchhof P
EUR HEART J. 2024 [Epub ahead of print].

Clinical effectiveness of patient-targeted feedback following depression screening in general practice (GET.FEEDBACK.GP): an investigator-initiated, prospective, multicentre, three-arm, observer-blinded, randomised controlled trial in Germany
Löwe B, Scherer M, Braunschneider L, Marx G, Eisele M, Mallon T, Schneider A, Linde K, Allwang C, Joos S, Zipfel S, Schulz S, Rost L, Brenk-Franz K, Szecsenyi J, Nikendei C, Härter M, Gallinat J, König H, Fierenz A, Vettorazzi E, Zapf A, Lehmann M, Kohlmann S
LANCET PSYCHIAT. 2024;11(4):262-273.

Prognostic Relevance of Ischemic Late Gadolinium Enhancement in Apparently Healthy Endurance Athletes: A Follow-up Study Over 5 years
Lund G, Leptin S, Ragab H, Sinn M, Fierenz A, Cavus E, Muellerleile K, Chen H, Erley J, Harms P, Kisters A, Starekova J, Adam G, Tahir E
SPORTS MED-OPEN. 2024;10(1):.

Letzte Aktualisierung aus dem FIS: 24.04.2024 - 00:35 Uhr